Toth Christopher A. 4
4 · VARIAN MEDICAL SYSTEMS INC · Filed Apr 16, 2021
Insider Transaction Report
Form 4
Toth Christopher A.
SVP and Pres. Oncology Systems
Transactions
- Disposition to Issuer
Common Stock
2021-04-15−15,418→ 0 total - Disposition to Issuer
Restricted Stock Units
2021-04-15−1,816→ 0 total→ Common Stock (1,816 underlying) - Disposition to Issuer
Performance Shares
2021-04-15−8,437→ 0 total→ Common Stock (8,437 underlying) - Disposition to Issuer
Restricted Stock Units
2021-04-15−633→ 0 total→ Common Stock (633 underlying) - Disposition to Issuer
Performance Shares
2021-04-15−6,415→ 0 total→ Common Stock (6,415 underlying)
Footnotes (8)
- [F1]Amount of securities disposed of reflect 196 shares purchased on April 8, 2021 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan and a reduction of 8 shares as a result of a tax correction for the February 16, 2021 RSU vesting.
- [F2]Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.
- [F3]Each restricted stock unit represents a contingent right to receive one share of VAR common stock.
- [F4]Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 14, 2020, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.
- [F5]Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 15, 2021, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.
- [F6]Each performance stock unit represents a contingent right to receive one share of VAR common stock.
- [F7]Pursuant to the Merger Agreement, these performance stock units, which were granted November 15, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
- [F8]Pursuant to the Merger Agreement, these performance stock units, which were granted November 21, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.